The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock
The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock
Business /  Companies

Reform has unleashed Chinese drugs innovation boom, though some pharma firms may not survive under intense price pressure, industry leaders say

  • Sales of newly developed medicines, or novel drugs, could more than triple to 960 billion yuan in the eight years to 2025, according to forecasts
  • Price pressure could spell the end for drug makers that fail to innovate, an industry conference hears

Topic |   Health & Fitness
Eric Ng
Eric Ng

Updated: 11:59am, 15 Jan, 2021

Why you can trust SCMP
The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock
The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock

Corrected [11:58am, 15 Jan, 2021]

  • [11:58am, 15 Jan, 2021]

    Corrects insurance claims amount to 1.85 trillion yuan in third paragraph from the end

    • We are part of the Trust Project What is it?
READ FULL ARTICLE